/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Zentek Ltd Share Price Today: Live Updates & Key Insights

Zentek Ltd share price today is $0.652, up -1.86%. The stock opened at $0.631 against the previous close of $0.652, with an intraday high of $0.6361 and low of $0.612.

Zentek Ltd Share Price Chart

style
pb-0

Zentek Ltd

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Zentek Ltd Share Price Performance

$0.652 -0.0186(-1.86%) ZTEK at 13 Mar 2026 04:01 PM Medical Instruments & Supplies
Lowest Today 0.612
Highest Today 0.6361
Today’s Open 0.631
Prev. Close 0.652
52 Week High 1.84
52 Week Low 0.54
Day’s Range: Low 0.612 High 0.6361
52-Week Range: Low 0.54 High 1.84
1 day return -
1 Week return -0.6
1 month return -1.05
3 month return -8.11
6 month return -32.8
1 year return -29.03
3 year return -57.73
5 year return -
10 year return -

Zentek Ltd Institutional Holdings

Scotia Capital Inc 0.82

Royal Bank of Canada 0.25

Federation des caisses Desjardins du Quebec 0.14

CIBC World Markets Inc. 0.13

Bank of Montreal 0.05

BMO Capital Markets Corp. 0.05

Fidelity Nasdaq Composite Index 0.05

Geode Capital Management, LLC 0.05

Renaissance Technologies Corp 0.04

JPMorgan Chase & Co 0.04

AQR Capital Management LLC 0.03

Creative Planning Inc 0.03

TD Waterhouse Canada Inc 0.03

CAMBRIDGE Invest RESEARCH ADVISORS, INC. 0.02

K.j. Harrison & Partners Inc 0.01

Cubist Systematic Strategies, LLC 0.01

Kestra Advisory Services, LLC 0.01

Virtu Financial LLC 0.01

Baader Bank INC 0.01

Morgan Stanley - Brokerage Accounts 0.01

NATIONAL BANK OF CANADA /FI/ 0.01

Zentek Ltd Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Zentek Ltd Fundamentals

Market Cap 70.12 M

PB Ratio 7.6914

PE Ratio 0.0

Enterprise Value 68.93 M

Total Assets 18.40 M

Volume 56150

Zentek Ltd Company Financials

Annual Revenue FY25:872495 0.9M, FY24:29816 0.0M, FY23:72855 0.1M

Annual Profit FY25:192485 0.2M, FY24:-301264 -0.3M, FY23:-857010 -0.9M

Annual Net worth FY25:-10039658 -10.0M, FY24:-11703990 -11.7M, FY23:-14414266 -14.4M

Quarterly Revenue Q4/2025:65225 0.1M, Q3/2025:6204 0.0M, Q2/2025:57797 0.1M, Q1/2025:813596 0.8M, Q4/2024:37718 0.0M

Quarterly Profit Q4/2025:-1276585 -1.3M, Q3/2025:-768 -0.0M, Q2/2025:27196 0.0M, Q1/2025:546092 0.5M, Q4/2024:-119991 -0.1M

Quarterly Net worth Q4/2025:-2486123 -2.5M, Q3/2025:-2391190 -2.4M, Q2/2025:-1362348 -1.4M, Q1/2025:-1839671 -1.8M, Q4/2024:-2601769 -2.6M

About Zentek Ltd & investment objective

Company Information Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Organisation Medical Instruments & Supplies

Employees 18

Industry Medical Instruments & Supplies

CEO Mr. Mohammed Jiwan

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow